- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03271970
The Anatomic Determinants of Perforation Induced Hearing Loss
February 5, 2018 updated by: Duke University
The purpose of this study is to identify factors that may contribute to conductive hearing loss.
Conductive hearing loss is a type that is due to a problem with the outer or middle ear.
Because of this, sound does not travel through the ear normally.
Perforated tympanic membranes of study patients will be photographed during the patient's routine visit using a digital otoscope.
These pictures will be used to analyze perforation size as an absolute value as well as a percentage of the tympanic membrane.
Audiometric results and CT scans of temporal bone (reports and images) collected as standard of care will be evaluated.
Images of CT scans will be imported into a medical imaging software for creation of anatomically realistic 3D models of the middle ear and mastoid air space.
Structural analysis on each 3D model will be conducted and analyzed, the volume of middle ear and mastoid air spaces will be recorded, and data points will be correlated with perforation size and location to audiogram results.
Study Overview
Status
Withdrawn
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult patients with conductive hearing loss due to tympanic membrane perforation.
Description
Inclusion Criteria:
- Between 18 and 89 years of age
- Confirmed diagnosis of conductive hearing loss secondary to tympanic membrane perforation
- Treated for the above condition by a Duke physician
- Received both a CT temporal bone scan interpreted by a Duke radiologist and audiometry at a Duke-based facility (both tests performed within four weeks of each other), as part of standard pre-operative workup
Exclusion Criteria:
- Temporal CT scan with inadequate resolution as per determination of study staff
- Unable to provide written informed consent
- Unable to read and understand English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients with conductive hearing loss
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
presence of perforation
Time Frame: Day 1
|
Number of patients with perforations
|
Day 1
|
absence of perforation
Time Frame: Day 1
|
number of patients without perforations
|
Day 1
|
change in audiometric measurements
Time Frame: Baseline, up to 16 weeks
|
looking at difference between baseline and last observation
|
Baseline, up to 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2017
Primary Completion (Actual)
January 3, 2018
Study Completion (Actual)
January 3, 2018
Study Registration Dates
First Submitted
August 17, 2017
First Submitted That Met QC Criteria
September 1, 2017
First Posted (Actual)
September 5, 2017
Study Record Updates
Last Update Posted (Actual)
February 6, 2018
Last Update Submitted That Met QC Criteria
February 5, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00073436
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Conductive Hearing Loss
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
Oticon MedicalSahlgrenska University Hospital, SwedenCompletedConductive Hearing Loss | Mixed Hearing LossSweden
-
Audioptics Medical IncorporatedNot yet recruitingConductive Hearing Loss, Middle Ear
-
Oticon MedicalActive, not recruitingConductive Hearing Loss | Mixed Hearing LossSweden
-
Oticon MedicalCompletedConductive Hearing Loss | Mixed Hearing Loss | Unilateral Partial DeafnessSweden
-
Oticon MedicalCompletedConductive Hearing Loss | Unilateral Partial Deafness | Mixed Conductive-sensorineural Hearing LossNetherlands
-
Khon Kaen UniversityPrince of Songkla University; Chiang Mai UniversityNot yet recruitingNormal Hearing | Conductive Hearing Loss, Middle EarThailand
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossUnited States, Netherlands, Australia, Germany, Poland
-
CochlearCompletedConductive Hearing Loss | Deafness; Sensoneural Single Sided | Mixed Hearing LossAustralia